BioScrip Prices New Stock Issue

BioScrip (NASDAQ: BIOS  ) is to float a 12.5 million-strong offering of its common stock in an underwritten public offering. That amount includes 3.125 million shares being offered by selling stockholders. The price has been set at $12.00 per share. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 1.875 million shares.

BioScrip estimates it will reap proceeds of roughly $106.5 million, and will use the monies for "general corporate purposes." It will not take in any proceeds from the shares offered by the selling stockholders.

Leucadia's (NYSE: LUK  ) Jefferies, Morgan Stanley (NYSE: LUK  ) , and SunTrust's Robinson Humphrey unit are the joint book-running managers of the issue.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2374654, ~/Articles/ArticleHandler.aspx, 4/24/2014 5:18:05 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement